These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3056533)

  • 21. [Urinary infections in children].
    Denis R; De Meuter F
    Arch Fr Pediatr; 1978; 35(7):726-36. PubMed ID: 367309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [O- and H-antigens of Escherichia coli K5 isolates in the urine].
    Nimmich W; Zingler G; Falkenhagen U; Naumann G; Kontny I
    Z Urol Nephrol; 1988 Apr; 81(4):257-61. PubMed ID: 2456647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.
    Ejrnæs K
    Dan Med Bull; 2011 Apr; 58(4):B4187. PubMed ID: 21466767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced carcinogenesis by urinary tract infection in rats.
    Johansson SL; Anderström C; von Schultz L; Larsson P
    Cancer Res; 1987 Jan; 47(2):559-62. PubMed ID: 3539325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli.
    Billips BK; Forrestal SG; Rycyk MT; Johnson JR; Klumpp DJ; Schaeffer AJ
    Infect Immun; 2007 Nov; 75(11):5353-60. PubMed ID: 17724068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Preliminary results of the vaccine treatment of chronic pyelonephritis in animal experiments].
    Straube E; Broschewitz U; Schill H; Naumann G
    Z Urol Nephrol; 1984 Jul; 77(7):401-5. PubMed ID: 6385543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies in Escherichia coli urinary tract infection.
    Fries D; Delavelle F; Mathieu D; Jacques L; Renault L
    Proc Eur Dial Transplant Assoc; 1977; 14():535-40. PubMed ID: 341144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. K antigens of Escherichia coli and virulence in urinary-tract infection: studies in a mouse model.
    Verweij-van Vught AM; van den Bosch JF; Namavar F; Sparrius M; MacLaren DM
    J Med Microbiol; 1983 May; 16(2):147-55. PubMed ID: 6341596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The role of E. coli adhesiveness in the pathogenesis and clinical course of urinary tract infections].
    Krzeska I; Ostojska J; Dzierzanowska D
    Pol Tyg Lek; 1992 Aug 7-17; 47(31-33):706-9. PubMed ID: 1362812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of immunization with Escherichia coli J5 on the course of experimental pyelonephritis in rats].
    Straube E; Naumann G; Broschewitz U
    Z Urol Nephrol; 1988 Apr; 81(4):247-55. PubMed ID: 3041706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The dulcitol test in strains of Escherichia coli isolated from urinary infections and feces].
    Zilleruelo G; Saieh C; Córdova M
    Rev Chil Pediatr; 1977; 48(2):89-91. PubMed ID: 360316
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of orally-administered Lactobacillus plantarum LPLM-O1 strain in an immunosuppressed mouse model of urinary tract infection.
    de Arellano AR; Sánchez M; Vera R; Jara S; González M; Castro E
    Benef Microbes; 2012 Mar; 3(1):51-9. PubMed ID: 22348909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental and clinical results with the Corynebacterium granulosum-derived immunomodulator P40.
    Bizzini B; Henocq E; Reynier J; Relyveld EH
    Asian Pac J Allergy Immunol; 1984 Jun; 2(1):144-53. PubMed ID: 6529476
    [No Abstract]   [Full Text] [Related]  

  • 34. Occurrence of infection following prostate biopsy procedures in Japan: Japanese Research Group for Urinary Tract Infection (JRGU) - a multi-center retrospective study.
    Togo Y; Kubo T; Taoka R; Hiyama Y; Uehara T; Hashimoto J; Kurimura Y; Takahashi S; Tsukamoto T; Miyazaki J; Nishiyama H; Kira S; Kiyota H; Yazawa S; Niwa N; Hongo H; Oya M; Kato T; Yasuda M; Deguchi T; Ishikawa K; Hoshinaga K; Matsumoto M; Shigemura K; Tanaka K; Arakawa S; Fujisawa M; Wada K; Uehara S; Watanabe T; Kumon H; Kobayashi K; Matsubara A; Matsumoto M; Sho T; Hamasuna R; Matsumoto T; Hayami H; Nakagawa M; Yamamoto S
    J Infect Chemother; 2014 Apr; 20(4):232-7. PubMed ID: 24594451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation of the gene encoding cytotoxic necrotizing factor type 1 (cnf(1)) attenuates the virulence of uropathogenic Escherichia coli.
    Rippere-Lampe KE; O'Brien AD; Conran R; Lockman HA
    Infect Immun; 2001 Jun; 69(6):3954-64. PubMed ID: 11349064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-even-related bacteriophages as candidates for treatment of Escherichia coli urinary tract infections.
    Nishikawa H; Yasuda M; Uchiyama J; Rashel M; Maeda Y; Takemura I; Sugihara S; Ujihara T; Shimizu Y; Shuin T; Matsuzaki S
    Arch Virol; 2008; 153(3):507-15. PubMed ID: 18188500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A study of urinary tract infection. III. On the immune interferon due to E.coli infection in the urinary tract (author's transl)].
    Okamura T
    Nihon Hinyokika Gakkai Zasshi; 1978 Jan; 69(1):1-5. PubMed ID: 349215
    [No Abstract]   [Full Text] [Related]  

  • 38. [Protective effects of snake venom antimicrobial peptide OH-CATH on E. coli induced rabbit urinary tract infection models].
    Zhang BY; Li SM; Gao ZH; Shen JH
    Dongwuxue Yanjiu; 2013 Feb; 34(1):27-32. PubMed ID: 23389975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Escherichia coli K antigen.
    Kaijser B; Vahlne G
    Zentralbl Bakteriol Orig A; 1979 Apr; 243(2-3):271-88. PubMed ID: 377857
    [No Abstract]   [Full Text] [Related]  

  • 40. The leucocyte migration test in urinary tract infection.
    Bailey RR; Roberts AP; Rowe B; Gross RJ; Dumonde DC
    N Z Med J; 1974 Jul; 80(519):10-5. PubMed ID: 4607203
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.